Literature DB >> 17234718

Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.

Vyomesh Patel1, Hans M Rosenfeldt, Ruth Lyons, Joan-Marc Servitja, Xosé R Bustelo, Mary Siroff, J Silvio Gutkind.   

Abstract

The poor prognosis associated with head and neck squamous cell carcinoma (HNSCC) is primarily due to both local invasion and the regional and/or distant metastatic spread. Recent findings have provided evidence that the acquisition of a motile and invasive phenotype by cancer cells involves the dysregulated function of key intracellular molecular mechanisms together with aberrant signaling events initiated by the surrounding microenvironment. These intrinsic and extrinsic biochemical pathways in turn often converge to stimulate the activity of members of the Rho family of Ras-related guanosine triphosphate (GTP)-binding proteins, including RhoA, Rac and Cdc42, which control the organization of the actin cytoskeleton thereby regulating cell adhesion, polarity and motility. In this study, we examined the status of activation of these GTPases in a representative collection of HNSCC cell lines. Surprisingly, we found that most HNSCC cells exhibit remarkably high levels of GTP-bound Rac1. Further analysis revealed that the activation of Rac1 in these HNSCC cells could be due to two independent signaling events, an epidermal growth factor receptor (EGFR)-based autocrine loop that leads to the activation of the Rac1 exchange factor Vav2 and an EGFR/Vav2-independent pathway that arises as a consequence of the oncogenic mutation of the H-ras proto-oncogene. Indeed, we provide evidence that the EGFR/Vav2/Rac1 axis is a crucial pathway for the acquisition of motile and invasive properties of most HNSCC cells. These findings shed light onto the molecular mechanisms involved in HNSCC cell invasion, and may reveal new therapeutic opportunities to halt the metastatic spread of these aggressive malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234718     DOI: 10.1093/carcin/bgm008

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  46 in total

Review 1.  Molecular parameters of head and neck cancer metastasis.

Authors:  Sanjay L Bhave; Theodoras N Teknos; Quintin Pan
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

3.  Mechanistic analysis of the amplification and diversification events induced by Vav proteins in B-lymphocytes.

Authors:  María J Caloca; José L Zugaza; Xosé R Bustelo
Journal:  J Biol Chem       Date:  2008-10-29       Impact factor: 5.157

4.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

5.  Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions.

Authors:  Panomwat Amornphimoltham; Kantima Leelahavanichkul; Alfredo Molinolo; Vyomesh Patel; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2008-12-10       Impact factor: 12.531

Review 6.  Epidermal stem cells in skin homeostasis and cutaneous carcinomas.

Authors:  S Aznar Benitah
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

7.  Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Authors:  Poonam R Molli; Liana Adam; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Endogenous RhoG is rapidly activated after epidermal growth factor stimulation through multiple guanine-nucleotide exchange factors.

Authors:  Thomas Samson; Christopher Welch; Elizabeth Monaghan-Benson; Klaus M Hahn; Keith Burridge
Journal:  Mol Biol Cell       Date:  2010-03-17       Impact factor: 4.138

9.  Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29).

Authors:  Joanne F Doleman; John J Eady; Ruan M Elliott; Rob J Foxall; John Seers; Ian T Johnson; Elizabeth K Lund
Journal:  Nutr Metab (Lond)       Date:  2010-07-12       Impact factor: 4.169

10.  Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.

Authors:  Cynthia Lopez-Haber; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2013-03-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.